Cliff Asness's CRL Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 0 shares of Charles River Laboratories International, Inc. (CRL) worth $0, representing 0.00% of the portfolio. First purchased in , this recently established position has been held for 0 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in CRL, representing a fresh investment thesis on this company. Largest addition occurred in Q3 2017, adding 405,859 shares. Largest reduction occurred in Q2 2020, reducing 631,701 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Charles River Laboratories International (CRL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Charles River Laboratories International (CRL) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| No data available | ||||
Cliff Asness's Charles River Laboratories International Investment FAQs
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 265,083 shares of Charles River Laboratories International, Inc. (CRL), valued at approximately $39.52 M.
As of the Q3 2025 filing, Charles River Laboratories International, Inc. (CRL) represents approximately 0.03% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Charles River Laboratories International, Inc. (CRL) was 2,239,921 shares, as reported at the end of Q2 2019.